MetaCap

enGene Therapeutics Inc. (ENGN)

NASDAQ: ENGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.75-0.055 (-3.06%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

ENGN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$116.94M
EPS (TTM)
-$2.00
52-week range
1.40 – 12.25
Day range
1.74 – 1.86
Volume / Avg
708.29K / 759.27K
Beta
—

52-week range

$1.40$12.25

ENGN stock today

Shares of enGene Therapeutics (ENGN) finished lower on Oct 7 at $1.75, a drop of 3.06% or $0.055 per share, versus the S&P 500's 0.22% decline. At this level, ENGN sits near the bottom of its 52-week range of $1.40 to $12.25: 85.8% below the high, set on Jan 23, 2026 and 24.6% above the low. ENGN is down 80.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 75.1%.

enGene Therapeutics has posted a net loss over the last twelve months (EPS of -$2.00), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About enGene Therapeutics

Company profile
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
Saint-Laurent

enGene Therapeutics peers

Health Care sector
ENGN peer companies
CompanyPrice% ChgMarket capCompare
LENZLENZ Therapeutics Inc.3.62-4.49%$113.74Mvs ENGN
BDTXBlack Diamond Therapeutics Inc.1.83+1.67%$104.86Mvs ENGN
ATRAAtara Biotherapeutics Inc.9.37-3.90%$94.05Mvs ENGN
CGTXCognition Therapeutics Inc.0.9366-0.36%$89.06Mvs ENGN
NMRANeumora Therapeutics Inc.0.4683-0.57%$87.99Mvs ENGN
CRDFCardiff Oncology Inc.1.09+1.87%$84.80Mvs ENGN
PTHSPelthos Therapeutics Inc.20.99-2.28%$80.36Mvs ENGN
GRMLGreenland Mines Ltd.5.83-8.62%$77.81Mvs ENGN

Indexes, lists and sector

enGene Therapeutics stock FAQ

What is enGene Therapeutics's stock price today?

ENGN last traded at $1.75 as of Oct 7, 4:00 PM EDT, down 3.06% on the day. Prices are delayed at least 15 minutes.

What is the ENGN 52-week high?

The 52-week high for ENGN is $12.25 and the 52-week low is $1.40. The stock is currently 85.8% below its high.

Compare ENGN